Allison Jeynes-Ellis - Feb 5, 2024 Form 4 Insider Report for AGENUS INC (AGEN)

Role
Director
Signature
/s/Christine Klaskin, as Attorney-in-Fact for Allison Jeynes-Ellis
Stock symbol
AGEN
Transactions as of
Feb 5, 2024
Transactions value $
$0
Form type
4
Date filed
4/22/2024, 04:05 PM
Previous filing
Feb 8, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGEN Stock Option Award $0 +5K $0.00 5K Feb 5, 2024 Common Stock 5K $12.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Options were awarded in accordance with the Agenus Inc. 2019 Amended and Restated Equity Incentive Plan on February 5, 2024 and will vest on February 5, 2025. The Stock Options were granted prior to the 1 for 20 reverse stock split, representing 100,000 Stock Options with an exercise price of $0.63.